SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-284839
Filing Date
2021-09-28
Accepted
2021-09-28 07:10:57
Documents
13
Period of Report
2021-09-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200964d8k.htm   iXBRL 8-K 60827
2 EX-99.1 d200964dex991.htm EX-99.1 40267
  Complete submission text file 0001193125-21-284839.txt   235204

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alt-20210928.xsd EX-101.SCH 2879
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20210928_lab.xml EX-101.LAB 18138
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20210928_pre.xml EX-101.PRE 11400
6 EXTRACTED XBRL INSTANCE DOCUMENT d200964d8k_htm.xml XML 3349
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 211283567
SIC: 2834 Pharmaceutical Preparations